Trends in childhood type 1 diabetes incidence in France, 2010-2015.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 04 04 2018
revised: 24 10 2018
accepted: 05 11 2018
pubmed: 16 11 2018
medline: 7 5 2019
entrez: 16 11 2018
Statut: ppublish

Résumé

To estimate type 1 diabetes incidence in children in France and its evolution between 2010 and 2015, based on comprehensive medico-administrative databases. The algorithm built to identify new cases of type 1 diabetes selected children aged between 6 months and 14 years who had at least one hospital stay for diabetes, followed by their first insulin treatment, excluding children suffering from another form of diabetes. Age and sex specific annual incidence rates were estimated and time trend was analyzed using Poisson regression. A total of 12 067 children were identified as newly diagnosed with type 1 diabetes and the annual incidence rates increased between 2010 and 2015 (from 15.4 [95% Confidence Interval: 14.7; 16.1] to 19.1 [18.3; 19.9] per 100 000 person-years), among boys and girls, and in each age group (4 and under, 5-9, 10-14 year olds). The annual rate of increase was 4.0% [3.4; 4.6]. This trend was not significantly different between each gender, and each age group. Valid database information on disease incidence is essential for healthcare planning and provides a valuable resource for health research. An increase of the incidence rate of type 1 diabetes in children was highlighted in both sexes and in all age groups.

Identifiants

pubmed: 30439385
pii: S0168-8227(18)30466-2
doi: 10.1016/j.diabres.2018.11.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

200-207

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Clara Piffaretti (C)

Santé publique France, The French National Public Health Agency, 12 rue du Val d'Osne, 94410 Saint Maurice, France. Electronic address: clara.piffaretti@santepubliquefrance.fr.

Laurence Mandereau-Bruno (L)

Santé publique France, The French National Public Health Agency, 12 rue du Val d'Osne, 94410 Saint Maurice, France.

Sophie Guilmin-Crepon (S)

Clinical Epidemiology Unit and Endocrinology and Diabetology Service, University Hospital Robert Debré at Assistance publique - Hôpitaux de Paris, 48 Bd Sérurier, 75019 Paris, France.

Carine Choleau (C)

AJD (Aide aux Jeunes Diabétiques), Help to the Young Diabetics, 38 Rue Eugène Oudiné, 75013 Paris, France.

Régis Coutant (R)

Pediatric Endocinology Service, University Hospital of Angers, 4 Rue Larrey, 49100 Angers, France.

Sandrine Fosse-Edorh (S)

Santé publique France, The French National Public Health Agency, 12 rue du Val d'Osne, 94410 Saint Maurice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH